Biologically active compounds

Details for Australian Patent Application No. 2003255711 (hide)

Owner Amura Therapeutics Limited

Inventors Ray, Peter Christopher; Watts, John Paul; Quibell, Martin

Agent Davies Collison Cave

Pub. Number AU-B-2003255711

PCT Number PCT/GB03/02957

PCT Pub. Number WO2004/007501

Priority 0217239.3 25.07.02 GB; 60/418,524 15.10.02 US; 0216525.6 16.07.02 GB

Filing date 15 July 2003

Wipo publication date 2 February 2004

Acceptance publication date 13 November 2008

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 0217239.3 25.07.02 GB; 60/418,524 15.10.02 US; 0216525.6 16.07.02 GB

18 March 2004 Application Open to Public Inspection

  Published as AU-B-2003255711

13 November 2008 Application Accepted

  Published as AU-B-2003255711

19 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003255712-4-(2-fluorophenyl)-6-methyl-2(1-piperazi nyl)thieno(2,3-D) pyrimidine in the treatment of functional bowel disorder

2003255710-TROCAR SHIELD ACTUATOR MECHANISM